Wednesday, Dec 11 2024 | Time 21:02 Hrs(IST)
image
Business EconomyPosted at: Nov 9 2024 9:29PM


Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore

Hyderabad, Nov 9 (UNI) Aurobindo Pharma, an integrated global pharmaceutical company, reported a consolidated net profit of Rs 817 crore for the quarter that ended September 30, 2024, up 8.6 percent from Rs 752 crore a year ago.
Consolidated Revenue from Operations during the quarter increased by 8 percent Y-o-Y to Rs 7,796 crore with growth across the businesses, Hyderabad-based pharma company said in a release here on Saturday.
In Q2FY24, the company’s revenues stood at Rs 7,219 crore
Operational Performance (Consolidated), the company said that its revenues from US formulations (excluding Puerto Rico) increased by 4.3 percent YoY to Rs 3,530 crore (USD 421 million) while from Europe formulations increased by 19 percent YoY to Rs 2,105 crore (EUR 229 million) and growth Markets revenue up by 44 percent YoY to Rs 812 crores (USD 97 million).
The Pharma Company spent Rs 410 crore, 5.3 percent on revenues on Research & Development (R&D including depreciation).
Commenting on the Company’s performance, Aurobindo Vice-Chairman and Managing Director K. Nithyananda Reddy, said: "We are pleased with the continued growth in revenues across our key business areas this quarter, reflecting the resilience of our diversified portfolio. While profitability saw a slight dip, primarily due to the transient nature of certain business activities, our underlying performance remains strong. With a solid foundation and ongoing operational improvements, we are confident of maintaining our growth trajectory and achieving our strategic objectives for the year."
The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally in over 150 countries.
The company has 29 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.
UNI KNR BD
Please log in to get detailed story.
Tags: #Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore
More News

Jubilant Bhartia Group to pick up 40 pc equity stake in Hindustan Coca-Cola holdings

11 Dec 2024 | 5:43 PM

New Delhi, Dec 11 (UNI) The Jubilant Bhartia Group on Wednesday said that they have entered into a definitive agreement for a strategic investment whereby the Jubilant Bhartia Group will be acquiring a 40% equity interest in Hindustan Coca-Cola Holdings Private Limited, India (HCCH) through its entity Jubilant Beverages Limited.

see more..

Tata Power, Tivolt Electric Vehicles partner to strengthen EV Charging Infrastructure

11 Dec 2024 | 5:38 PM

New Delhi, Dec 11 (UNI) Tivolt Electric Vehicles Private Limited (Tivolt), an EV venture of the Murugappa Group and a subsidiary of TI Clean Mobility, has signed a Memorandum of Understanding (MOU) with Tata Power Renewable Energy Limited (TPREL), a prominent EV charging solutions provider, to enhance e-mobility for commercial vehicles across the country.

see more..

Vodafone Idea adopts Nokia AI-powered MantaRay SON Solution

11 Dec 2024 | 5:35 PM

New Delhi, Dec 11 (UNI) Telecom equipment major Nokia today said it has successfully deployed its cutting-edge AI-powered MantaRay SON (Self-Organizing Networks) solution in Vodafone Idea’s (Vi) 4G and (soon to be launched) 5G networks across India, to ensure seamless, high-capacity and energy efficient connectivity for Vi customers.

see more..

Kottayam-Kochi Rubber market rates

11 Dec 2024 | 5:13 PM

Kottayam Dec 11 (UNI) Following were the Rubber Market rates per quintal announced by the Rubber Board here on Wednesday.

see more..

Linux Foundation launches LF India to expand global open source support and innovation

11 Dec 2024 | 4:58 PM

Chennai, Dec 11 (UNI) The Linux Foundation, the nonprofit organization enabling mass innovation through open source, on Wednesday announced the establishment of the LF India to expand global open source support and innovation.

see more..
image